Fidelity Disruptive Medicine ETF Rating $31.92 -0.06 (-0.19%) As of 02:26 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.72Holdings in FMED have an aggregate rating of Moderate Buy based on 443 analyst ratings issued in the past year covering 22 companies (55.2% of the portfolio).FMED Aggregate Price Target$31.92High Prediction$31.92Average Prediction$31.92Low Prediction$31.92Holdings in FMED have an aggregate price target of $31.92 and a range of $31.92 to $31.92 covering 22 companies (55.2% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 FMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.26%TXG10x Genomics$63.22+2.5%1.382 of 5 stars2.24$40.57 -35.8%17Analyst Forecast3.90%TMOThermo Fisher Scientific$617.90+1.5%4.2871 of 5 stars2.88$625.00 1.1%24Positive NewsAnalyst Upgrade3.83%DHRDanaher$210.72+0.4%4.5434 of 5 stars2.84$228.91 8.6%25Positive News3.14%LFSTLifeStance Health Group$12.83-0.5%3.2677 of 5 stars2.73$12.38 -3.5%11Positive News3.03%RVMDRevolution Medicines$210.38+0.5%2.5165 of 5 stars2.95$200.74 -4.6%22Analyst ForecastInsider TradeAnalyst Revision2.87%COGTCogent Biosciences$34.88+0.9%2.4781 of 5 stars2.75$51.56 47.8%12Positive News2.81%ARGXargenex$1,055.48+0.0%3.8191 of 5 stars2.88$1,158.61 9.8%24Analyst Forecast2.65%ILMNIllumina$219.56+3.0%2.1624 of 5 stars2.39$191.31 -12.9%18Positive NewsAnalyst Forecast2.39%NTRANatera$326.42+0.4%2.4875 of 5 stars2.82$319.38 -2.2%22Positive News2.24%ISRGIntuitive Surgical$371.52-0.1%4.31 of 5 stars2.68$508.68 36.9%31Positive News2.20%KYMRKymera Therapeutics$116.10-2.1%1.8575 of 5 stars2.88$128.70 10.8%24News CoveragePositive NewsAnalyst Forecast2.20%ALNYAlnylam Pharmaceuticals$263.29-1.5%4.5974 of 5 stars2.88$386.14 46.7%25Analyst Forecast2.13%INSMInsmed$125.44-0.9%3.7117 of 5 stars3.00$205.52 63.8%252.01%ASNDAscendis Pharma A/S$270.10+1.0%4.269 of 5 stars3.05$310.05 14.8%20News CoverageAnalyst ForecastAnalyst Revision2.01%UNHUnitedHealth Group$400.49+0.2%4.8138 of 5 stars2.85$456.56 14.0%27Trending NewsAnalyst Forecast1.89%MRNAModerna$145.89-3.3%1.4947 of 5 stars2.08$76.72 -47.4%24Trending NewsAnalyst DowngradeOptions VolumeAnalyst RevisionGap Down1.88%HTFLHeartflow$49.22-1.6%2.2097 of 5 stars2.82$43.43 -11.8%11Positive News1.87%EWEdwards Lifesciences$89.93-1.0%3.6429 of 5 stars2.74$100.27 11.5%23Positive News1.86%KNSAKiniksa Pharmaceuticals International$80.11+0.3%3.4909 of 5 stars2.80$87.38 9.1%10Positive News1.84%PCVXVaxcyte$60.89-1.1%2.3877 of 5 stars2.50$86.00 41.2%8Positive NewsInsider Trade1.69%GHGuardant Health$160.85-1.4%3.16 of 5 stars2.96$183.78 14.3%25Analyst Forecast1.51%LEGNLegend Biotech$21.78-0.5%3.1978 of 5 stars2.47$52.29 140.1%15Analyst Upgrade This page (NASDAQ:FMED) was last updated on 9/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
